SLC10A2

Chr 13AR

solute carrier family 10 member 2

Also known as: ASBT, IBAT, ISBT, NTCP2, PBAM, PBAM1

This protein is a sodium/bile acid cotransporter that mediates reabsorption of bile acids in the distal ileum and renal proximal tubules, playing a critical role in enterohepatic circulation and cholesterol homeostasis. Mutations cause primary bile acid malabsorption, an autosomal recessive disorder affecting the gastrointestinal system. The gene shows high tolerance to loss-of-function variants (LOEUF 1.944), consistent with the recessive inheritance pattern.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

?Bile acid malabsorption, primary, 1MIM #613291
AR
0
Active trials
11
Pubs (1 yr)
74
P/LP submissions
0%
P/LP missense
1.94
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC10A2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
74 unique Pathogenic / Likely Pathogenic· 278 VUS of 500 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.94LOEUF
pLI 0.000
Z-score -2.02
OE 1.62 (1.111.94)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-2.20Z-score
OE missense 1.43 (1.301.58)
292 obs / 203.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.62 (1.111.94)
00.351.4
Missense OE1.43 (1.301.58)
00.61.4
Synonymous OE1.13
01.21.6
LoF obs/exp: 20 / 12.4Missense obs/exp: 292 / 203.5Syn Z: -0.98
DN
0.74top 25%
GOF
0.79top 25%
LOF
0.2191th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic73
Likely Pathogenic1
VUS278
Likely Benign105
Benign14
Conflicting27
73
Pathogenic
1
Likely Pathogenic
278
VUS
105
Likely Benign
14
Benign
27
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
73
0
73
Likely Pathogenic
0
0
1
0
1
VUS
20
222
34
2
278
Likely Benign
0
6
34
65
105
Benign
0
3
8
3
14
Conflicting
27
Total2023115070498

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC10A2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →